Featured News
Featured Pharmaceutical News
Flexion to Present New Cost-Effectiveness Data on Zilretta™ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting
Findings suggest Zilretta could potentially provide a cost-effective treatment option for patients with osteoarthritis of the knee BURLINGTON, Mass., May 22, 2017 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the findings from a new health economics analysis of Zilretta (also known as FX006), the company’s lead investigational candidate for the treatment of knee […]
Allergan’s Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications
Approximately Half of Americans Surveyed Notice the Eyes First, Supporting the Mission of the Campaign to Empower Chronic Dry Eye Sufferers to Take Action DUBLIN, May 16, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced the results of a new online eye language survey of 1,019 adult Americans that found approximately half of respondents […]
The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
Ethicon Plus Sutures are the only globally available sutures coated with triclosan that inhibit bacteria from colonizing the suture. Somerville, NJ – May 10, 2017 – Ethicon*, a trusted leader in suture technology, supports the Centers for Disease Control and Prevention’s (CDC) updated Guideline for the Prevention of Surgical Site Infection, 2017. Recently revised, the […]
Abbott Announces CE Mark for Tacticath™ Contact Force Ablation Catheter, Sensor Enabled™
New cardiac ablation catheter integrates with 3D mapping system to advance the treatment of atrial fibrillation ABBOTT PARK, Ill., May 9, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a […]
Abbott Announces CE Mark and First Use of the World’s First SmartPhone Compatible Insertable Cardiac Monitor
The new Confirm RX™ ICM automatically captures vital cardiac information and relays data to physicians via the myMerlin™ mobile app enabling remote monitoring of irregular heart rhythms ABBOTT PARK, Ill., May 8, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the […]
Abbott Announces National Reimbursement for Freestyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
FreeStyle® Libre system eliminates routine finger sticks(1) for glucose measurements and requires no finger sticks for calibration Now reimbursed in France, the second largest market(2) for FreeStyle Libre globally First-of-its-kind product now has full or partial reimbursement across 13 countries in Europe, including Austria, Germany, Italy and Sweden PARIS, May 8, 2017 /PRNewswire/ — Abbott today […]
Relvar Ellipta significantly improved asthma control in Salford Lung Study patients compared with their usual care
Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an improvement in asthma control compared with patients continuing usual care. London – 05 May 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva Inc (NASDAQ: INVA) today announced positive results from the innovative Salford Lung Study (SLS) in asthma, carried out […]
Real-World Evidence Shows Oral INVOKANA® 300 mg Demonstrates Comparable A1C Reduction and Control to Injectable GLP-1 Receptor Agonists
Patients Taking INVOKANA® 300 mg Were Significantly Less Likely to Discontinue the Medication or Be Prescribed a New Antihyperglycemic Agent Note: This release corresponds to American Association of Clinical Endocrinologists Annual Scientific & Clinical Congress Poster No. 290 TITUSVILLE, NJ, May 5, 2017 – Janssen Pharmaceuticals, Inc. (Janssen), today announced real-world evidence showing people with […]